Dermavon Holdings Limited
Clinical trials sponsored by Dermavon Holdings Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new skin gel fight stubborn bacterial infections? Results expected Jan 2027 (estimated)
- New eczema pill shows promise in early trial Results expected Jan 2027 (estimated)
-
New eczema pill shows promise in early trial
Disease control Not yet recruitingThis Phase 2 trial tests an experimental drug called CMS-D001 in 160 adults with moderate to severe atopic dermatitis (eczema) that hasn't responded well to creams. Participants will take one of three doses of the drug or a placebo daily for several weeks. The main goal is to see…
Phase 2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill could clear psoriasis in thousands
Disease control Not yet recruitingThis study tests an experimental tablet called CMS-D001 for adults with moderate to severe plaque psoriasis. About 540 participants will receive either the drug or a placebo to see if it improves skin symptoms like redness, scaling, and thickness. The goal is to measure how many …
Phase 2/3 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC